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Abstract: Carbonyl chemistry, specifically aldol reactions, is one of the most efficient and elegant strategies to 
build carbon-carbon bonds. In the last 15 years in Brazil, our research group and others have worked on the devel-
opment and application of stereoselective aldol reactions, with direct application in the asymmetric synthesis of 
several natural products of biological interest. In this review, we highlight the major Brazilian contributions to this 
field. 
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1. INTRODUCTION 
The aldol reaction is one of the most important and frequently 
applied synthetic methods for the creation of C-C bonds in organic 
molecules and plays a very important role in the synthesis of bioac-
tive natural products. The aldol reaction has been applied in the 
synthesis of several natural products with biological and pharma-
cological significance [1]. The construction of complex molecules 
requires that fragments must be joined at some point in the synthe-
sis, and the aldol reaction provides a very attractive method for 
incorporating convergence. Furthermore, the aldol reaction plays a 
key role in the biosynthesis of natural products by polyketide syn-
thase enzymes that organize the addition of malonyl Coenzyme-A 
or methylmalonyl Coenzyme-A to the growing natural product 
chain [2]. 
The term “aldol reaction”, coined by Wurtz in 1872 [3], de-
scribes the nucleophilic addition of an enolate (or enol) to a 
carbonyl compound, and the first known example was described in 
1864 [4]. In early development of the aldol reaction, only a few 
examples of stereoselective approaches were described. In the last 
century, a vast arsenal of stereoselective methods has been devel-
oped. Modern aldol reactions use preformed enolates to prevent 
side reactions. This methodology has been effective for various 
Lewis acids derived from lithium, titanium, tin, and boron [1]. Fur-
thermore, Mukaiyama aldol variants, employing Lewis-acid-
mediated additions of enolsilane derivatives, and organocatalytic 
approaches are other key strategies in the arsenal of stereoselective 
aldol methods [1]. 
Herein, we highlight the main contributions from research 
groups in Brazil in this field over the last 20 years. 
2. METAL PREFORMED ENOLATES 
Several factors relate to the selectivity of aldol reactions involv-
ing kinetic enolates and play key roles in the stereochemical control 
of the aldol adduct: the nature of the Lewis acid (e.g., Li, Mg, B, 
Al, Ti, and Sn), the presence of stereogenic centers in both partners 
and the nature of the double bond [1]. For most metal propionate 
enolates, the aldol reaction proceeds through a six-membered cyclic 
transition state, as proposed by Zimmerman and Traxler [5]. Ac-
cording to this model, the nature of the double bond governs the  
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simple diastereoselection in which the presented 1,3-diaxial interac-
tions are avoided. Both the enolate and aldehyde present two faces 
(re and si) leading to four possible face-to-face approximations 
(i.e., re-re, si-si, re-si, and si-re) [6]. Z-enolates lead to 1,2-syn 
aldol adducts, and E-enolates afford 1,2-anti relationships (Scheme 
1). If the aldehyde or enolate are chiral and the faces of the chiral 
reactants are more or less hindered, then one diastereoisomer can be 
produced with a high level of selectivity. 
2.1. Chiral Auxiliaries 
Over the past three decades, aldol reactions mediated by amino 
acid-derived heterocyclic chiral auxiliaries have been widely em-
ployed in asymmetric synthesis. Their utility lies in their facile 
introduction and removal of the chiral auxiliary without epimeriza-
tion of the desired products and their strong bias for a selective 
enolization and for enolate diastereoface discrimination. Today, 
many chiral auxiliaries are available that meet the above criteria in 
full or in part. 
The well-known Evans oxazolidinones, as well as the oxa-
zolidinethione and thiazolidinethione structural variants, are highly 
selective and efficient chiral auxiliaries (Fig. 1). Evans developed 
the popular chiral oxazolidinone, establishing the protocols using 
(n-Bu)2BOTf and tertiary amines [7]. Titanium enolates have also 
proved to be very useful. 
The selectivity for the Evans syn aldol adduct is explained by 
the transition state TS1 that minimizes the carbonyl-carbonyl dipole 
interactions and avoids steric interactions between CHR1 from the 
chiral auxiliary as the aldehyde approaches the enolate from the 
opposite side (Scheme 2) [8]. 
The Evans oxazolidinones have been widely used in Brazil, par-
ticularly by the Dias research group in the total synthesis of several 
natural products and biologically significant molecules. In the next 
sections, we intend to present the application of this strategy in the 
synthesis of several natural products and biological active products. 
2.1.1. Total Synthesis of (+)-Crocacin C and (+)-Crocacin D 
Crocacins A-D are a group of compounds that are regularly 
found in extracts of Chondromyces crocatus and Chondromyces 
pediulatus [9]. They are potent inhibitors of animal cell cultures and 
several yeasts and fungi and moderately inhibit the growth of a few 
Gram-positive bacteria. In 2001, Dias and Oliveira completed the 
total synthesis of (+)-crocacin C, which involved the asymmetric 
aldol reaction of a boron enolate derived from oxazolidinone 1 with 
cinnamaldehyde to give the Evans aldol adduct 2 in 85% isolated  
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Scheme 1. Simple diastereoselectivity of propionate aldol reactions. 
 


































































Scheme 2. Preparation of the Evans syn aldol adduct. 
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Scheme 4. Total synthesis of (–)-callystatin A. 
 
yield and greater than 95% diastereomeric purity, corresponding to 
the C17 C21 fragment (crocacin numbering) (Scheme 3) [10]. A 
few years later, the total synthesis of (+)-crocacin D was also com-
pleted by overcoming the challenge of constructing the Z-enamide 
functionality through the coupling of crocacin C and the Z-vinyl 
iodide derived from fragment C1 C9 [11]. 
2.1.2. Total Synthesis of (–)-Callystatin A 
Callystatin A, a potent antitumor polyketide, was isolated in 
1997 by Kobayashi et al., from the marine sponge Callyspongia 
truncata (Scheme 4) [12]. The chiral auxiliary strategy was em-
ployed in the total synthesis of (–)-callystatin A by Dias and Meira 
in 2005 [13]. They used a chiral aldehyde bearing a stereogenic 
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center at C20. Reaction of the boron enolate generated from 3 with 
2-(S)-methylbutanal gave aldol adduct 4 in 89% yield (dr > 95:5) to 
produce the C17–C22 fragment (callystatin A numbering). 
2.1.3. Total Synthesis of (–)-Pironetin 
Pironetin is an unsaturated -lactone derivative that has plant 
growth regulatory and immunosuppressive activities, biological 
effects on cell cycle progression and antitumor activities [14]. In 
2003, Dias et al., described the total synthesis of (–)-pironetin by a 
very aggressive use of the chiral auxiliary strategy (Scheme 5) [15]. 
The structure in Scheme 5 revealed three pairs of syn stereocenters 
(C4–C5, C7–C8, and C9–C10). To introduce these stereochemical 
centers, they explored three Evans aldol reactions involving oxa-
zolidinones 1, 3, and 9 in different stages of the synthesis. 
2.1.4. Synthesis of the 6,6-Spiroketal Cores of Spirofungins A and 
B 
Spirofungins A and B are polyketide-spiroketal antibiotics re-
lated to reveromycins that exhibit high inhibition of yeasts, such as 
the human pathogen Candida albicans, and moderate antifungal 
activity against filamentous fungi, such as Botrytis cinerea and 
Mucor miehei [16]. They were isolated as a 4:1 mixture (A:B) from 
culture filtrates and extracts of Streptomyces violaceusniger Tü 
4133. In 2004, Dias and Oliveira reported a short and efficient syn-
thesis of the C9–C20 6,6-spiroketal fragments 12 and 13 of both 
compounds (Scheme 6) [17]. The C18–C19 stereochemistry was 
installed by the Evans aldol reaction using oxazolidinone 1 to pro-
vide aldol adduct 11 with excellent yield and selectivity. 
2.1.5. Synthesis of (+)-Prelactone B 
Prelactones comprise a class of highly functionalized chiral -
lactones isolated from polyketide macrolide-producing microorgan-
isms [18]. A flexible enantioselective synthesis of (+)-prelactone B 
was accomplished by Dias et al., in 2004, starting with the anti-
aldol reaction between oxazolidinone 3 and methacrolein promoted 
by MgCl2, TMSCl, NaSbF6, and Et3N to give aldol adduct 14 with 
15:1 diastereoselectivity (Scheme 7) [19]. It is interesting that even 
though the enolate has a Z-geometry, the observed aldol adduct 14 
has the anti configuration, which precludes the use of a Zimmer-
man-Traxler model. The stereochemical outcome of this reaction 
can be rationalized by the transition state TS3, in which the magne-
sium ion coordinates to the aldehyde carbonyl, the enolate oxygen 
and the oxazolidinone carbonyl. The aldehyde approaches from the 
less hindered face of the enolate [20]. Further derivatization lead to 
aldehyde 15. The BF3-catalyzed Mukaiyama aldol reaction between 
a ketene silyl acetal and the aldehyde 15 provided the Felkin/1,3-
anti aldol adduct 16 in 75% yield and dr > 95:5, which gave (+)-
prelactone B in 77% yield after TBS removal and lactonization. 
2.1.6. Synthesis of the 6,6-Spiroketal Core of Routiennocin 
Routiennocin (Scheme 8), isolated in 1985 and possessing a 
6,6-spiroketal core, is an ionophore antibiotic belonging to the  
family of pyrrolocarbonyl spiroketal ionophore antibiotics capable 
of effecting proton-cation exchange across biological membranes 
and forming lipophilic complexes with metal cations [21]. In  
2007, Dias et al., disclosed a convergent synthesis of the 6,6-
spiroketal core of C8 C20 18 in routiennocin. The C17 C18  








































































































Scheme 5. Total synthesis of (–)-pironetin. 









































































































































Scheme 7. Total synthesis of (+)-prelactone B. 








































































































































Scheme 9. Synthesis of the C11 C23 fragment of dictyostatin. 
 
zolidinone 3 to produce the 1,2-syn anti-Felkin aldol adduct 17 in 
high yield and diastereoselectivity [22]. Again, the oxazolidinone 
overcame the preference of the aldehyde for Felkin-addition. 
2.1.7. Synthesis of the C11 C23 Fragment of Dictyostatin 
The macrolactone dictyostatin was first isolated by Pettit et al. 
presented potent antitumor activity through microtubule stabiliza-
tion [23]. Dias et al. reported the convergent synthesis of the 
C11 C23 fragment 21 of dictyostatin [24]. Two Evans aldol reac-
tions produced the C13 C14 and C20 C21 stereocenters in anti-
Felkin aldol adducts 19 and 20, respectively, in good yields and 
with high levels of diastereoselectivity (Scheme 9). 
2.1.8. Total Synthesis of Pteridic Acids A and B 
The pteridic acids A and B, isolated by Igarashi et al. from the 
fermentation broth of Streptomyces hygroscopicus TP-A0451, are 
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spirocyclic polyketides exhibiting potent plant growth promoter 
properties [25]. In 2009, Dias and Salles Jr. reported the total syn-
thesis of pteridic acids A and B, two of the most complex structures 
synthesized in Brazil, by applying different aldol inductions in a 
convergent strategy (Scheme 10) [26]. After an Evans aldol reac-
tion with the chiral auxiliary 1, they obtained aldol adduct 19 using 
the reaction shown in Scheme 9. Further derivatization lead to alde-
hyde 22. The lithium-mediated aldol reaction between the Z-enolate 
of the chiral ethyl ketone 23 with the aldehyde 22 produced the 
syn/anti-Felkin and syn/Felkin aldol adducts 24 and 25, respec-
tively, in 70% yield and dr = 80:20. These correspond to the 
C5 C15 fragments of the pteridic acids. The aldol reaction pro-
ceeds via a combination of the Zimmerman-Traxler model and the 
Felkin-Anh rule. As outlined by Roush and Gennari [27], the TS4 
(anti-Felkin addition) is the lowest in energy and avoids the 1,3-



















































































































































Scheme 10. Total synthesis of pteridic acids A and B. 
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2.1.9. Total Synthesis of ( )-Basiliskamide B 
The antifungal polyketide ( )-basiliskamide B was isolated 
from the marine bacterium PNG-276 [28]. In the synthesis of ( )-
basiliskamide B reported in 2008, Dias and Gonçalves employed an 
aldol reaction with the E-boron enolate generated from ethyl ketone 
26 leading to the formation of the 1,2-anti-1,4-syn aldol adduct 27 
in high yield and with good diastereoselectivity (Scheme 11) [29]. 
This precursor corresponds to fragment C5 C11 of ( )-
basiliskamide B. The observed diastereoselectivity can be explained 
by the boat-like transition state TS6 with hydrogen bonding be-
tween the -oxygen of the enolate and the formyl hydrogen of the 
complexed aldehyde. 
2.1.10. Formal Total Synthesis of Saliniketals A and B 
The marine-derived polyketides saliniketals A and B, isolated 
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Scheme 12. Synthesis of the C4 C17 fragment of saliniketals A and B. 
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[30]. A diastereoselective synthesis of the C4 C17 fragment of 
saliniketals A and B (formal total synthesis) was reported by Dias 
and Perez in 2013 (Scheme 12) [31].  
These authors employed an Evans aldol reaction using the 
chiral auxiliary 3 and a key aldol reaction mediated by titanium 
enolate involving ethyl ketone 28 [32]. The excellent diastereose-
lectivity observed for aldol adduct 29 can be explained by invoking 
TS7 [33]. The Z-enolate adopts a conformation in which the Me 
group is eclipsed by the double bond hydrogen. The model outlined 
by Roush and Gennari [27] illustrates the preferential face of the 
aldehyde. 
2.1.11. Synthesis of the Macrolactones of Migrastatin and Isomi-
grastatin and their Analogs 
The macrolactone polyketide of migrastatin was isolated from 
the culture broth of Streptomyces sp. MK 929-43F1 2000 [34]. This 
macrolactone and its analogs possess inhibitory effects against the 
migration of human tumor cells and are attractive lead compounds 
for the treatment of tumor metastasis [35]. Dias et al., synthesized 
the macrolactone core of migrastatin and several analogs starting 
with aldol adduct 30 as a synthetic intermediate. This aldol adduct 
was obtained in excellent yields and diastereoselectivities by the 
asymmetric aldol addition of the titanium enolate derived from 
oxazolidinone 3 to acrolein (Scheme 13) [36]. 
2.1.12. Synthesis of the Monomeric Polyketide Precursor of 
Elaiophylin 
The macrodiolide elaiophylin was isolated from cultures of 
Streptomyces melanosporus in 1959 by Arcamone et al. [37]. In 
2015, the research groups of Dias and Leadlay tried to understand 
the biosynthesis of elaiophylin (Scheme 14). Aldol adducts 32 and 
19 were used to prepare monomer analogs 33 and 34 [38]. Incuba-
tion of recombinant elaiophylin thioesterase/cyclase with monomer 
analog 34 produced a 16-membered C2-symmetric macrodiolide 
36. Incubation of a mixture of monomer analogs 33 and 34 gave a 
mixture of diolides 35 and 36. 
2.1.13. Synthesis of Prelog-Djerassi Lactone Derivative 
The Prelog-Djerassi lactone it’s an important synthetic target 
since its stereochemical pattern is found in many natural products. 
It was first isolated as a degradation product of same macrolide 
antibiotics. A synthesis of Prelog-Djerassi lactone analog was re-
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Scheme 13. Synthesis of the macrolactone of migrastatin and its analogs. 
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15) [39]. After an intramolecular alkylation, followed by an equili-
bration in t-BuOK/t-BuOH the lactone was obtained in 62% yield. 
2.2. 1,5-Remote Asymmetric Induction With -Alkoxy Meth-
ylketones 
The 1,5-asymmetric induction in aldol reactions of boron 
enolates of methylketones was first observed in 1989 by Masamune 
et al., [40] and has been studied over the last 26 years by several 
research groups [41]. The 1,5-anti or 1,5-syn remote asymmetric 
induction can be obtained from boron-mediated aldol reactions of 
-alkoxy methylketones by selecting the appropriate stereoelec-
tronic requirements. 
Paton and Goodman initiated our understanding of the 1,5-anti 
stereochemical bias, showing an energetic preference for the boat-
like six-membered cyclic transition state TS8, which places the -
alkoxy substituent into the six-membered ring to participate in a 
stabilizing H-bond with the formyl hydrogen (Scheme 16) [42]. 
Steric interactions between the R1 group and boron-ligands in TS9 
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Scheme 15. Synthesis of Prelog-Djerassi lactone analogs. 




































Scheme 16. Transition state for 1,5-anti aldol induction. 
Dias et al. have made a huge contribution in this field through 
several experimental and theoretical works. They started investigat-
ing the 1,5-anti induction of methylketone 37 bearing a stereogenic 
center alpha to the carbonyl (Scheme 17). High yields and excellent 
diastereoselectivities were achieved using achiral or chiral alde-
hydes, illustrating the remarkable influence of the resident -alkoxy 
group stereocenter on the stereochemical course of the aldol reac-
tions [43]. 
The Dias group also investigated the effect of the - and -
substituents in the -alkoxy methyl ketones. The -Me 38 and 
, , -syn 39 -alkoxy methylketones showed a sensible reduction 
in the 1,5-anti stereochemical bias (Scheme 18) [43c]. Theoretical 
studies involving the transition states of these reactions using sim-
pler models for methylketone and the aldehyde revealed a relation-
ship between the stereochemistry of the - and -methyl groups and 
selectivity that was not immediately obvious. The reduction for 1,5-
anti preference of the -Me methylketone 38 is due to an allylic 
strain A1,3 interaction of the -Me group and the double bond hy-
drogen in TS12. 
The authors observed that TS15, lacking an internal hydrogen 
bond, is the most stable for , , -syn methylketone 39. TS14 con-
tains a repulsion between the -Me and -Me substituents (Scheme 
18). The performance of the , -syn- -anti configuration was also 
optimized. By analogy, the high-energy preference for TS10 is due 
to severe steric repulsions presented between the -Me and -Me 
substituents in TS11 (Scheme 17). 
In 2012, Dias et al. evaluated the influence of the relative stere-
ochemistry between , -bisalkoxy methylketones 40 43 and the 
steric influence of cyclic protecting groups on the 1,5 selectivity in 
aldol reactions [44]. The aldol adducts were obtained with moderate 
to high degrees of 1,5-anti inductions (Scheme 19). Theoretical 
calculations rationalized the results, showing that all aldol reactions 
proceeded through the 1,5-induction model proposed by Goodman 
and Paton [42]. 
Dias et al., described good levels of 1,5-syn induction, occur-
ring independently of the stereoelectronic nature of the -alkoxy 
protecting group (Scheme 20) [45]. It is important to note that the 
literature indicates a close relationship between the nature of the -
alkoxy group and the sense of 1,5-induction [41]. From the experi-
mental and theoretical results obtained for methylketones 44 50, 
they concluded that the major contribution to the sense of 1,5-syn 
induction is correlated to the size of the alkyl substituent at the -
position of the boron enolate. However, the electronic effect is not 
negligible. Theoretical studies indicated that TS17 is responsible 
for the reversal in selectivity, keeping the bulky -substituent as far 
as possible from the boat ring and boron ligands. The competitive 
transition state TS18 orients the –OP group towards the boron 
ligands and increases its energy. 
2.2.1. Total Synthesis of ( )-Cryptocaryol A 
(+)-Cryptocaryol A was isolated in 2011 by Gustafson and co-
workers from a collection of the plant Cryptocarya sp. and exhibits 
a stabilizing activity towards Pdcd4 (programmed cell death 4), a 
tumor suppressor protein [46]. In 2015, Dias and co-workers re-
ported the total synthesis of ( )-Cryptocaryol A using three 1,5-anti 
aldol reactions involving methylketones 51, 53, and 55, although 
they observed low yields for this latter transformation (Scheme 21) 
[47]. 
2.2.2. Synthesis of the C29 C39 Fragment of Sanglifehrin A 
Sanglifehrin A is a potent immunosuppressant isolated from 
culture broths of Streptomyces flaveolus in 1977 [48]. In 2006, Dias 
and Salles Jr. described the synthesis of the C29 C39 fragment of 
sanglifehrin A [49]. They started with an Evans aldol reaction using 


































































Scheme 17. 1,5-Anti aldol induction of methylketone 37. Relative energies 
at MP2/6-31+G(d,p)//B3LYP/6-31G(d,p). 














































































































































Scheme 18. 1,5-Anti aldol inductions of methylketones 38 and 39. Relative energies at MP2/6-31+G(d,p)//B3LYP/6-31G(d,p). 
40 R1 = Me, X = C (1,3-trans)
41 R1 = Me, X = C (1,3-cis)
42 R1 =  t-Bu, X = Si (1,3-trans)


















Et3N, Et2O, –30 °C
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Scheme 19. 1,5-Anti aldol inductions of methylketones 40 43. 










44 P = Bn, R1 = CF3
45 P = TBS, R1 = CF3
46 P = Bn, R1 = CCl3
47 P = TBS, R1 = CCl3
48 P = PMB, R1 = t-Bu
49 P = TBS, R1 = t-Bu
50 P = TBS, R1 = CPh3
P = Bn, R1 = CF3,    dr ~ 65:35 
P = TBS, R1 = CF3,  dr ~ 80:20
P = Bn, R1 = CCl3,   dr ~ 90:10 
P = TBS, R1 = CCl3, dr ~ 80:20
P = PMB, R1 = t-Bu, dr ~ 80:20
P = TBS, R1 = t-Bu, dr ~ 65:35
P = TBS, R1 = CPh3, dr ~ 95:05
1) (c-Hex)2BCl, Et3N
Et2O or  CH2Cl2
0 °C or –30 °C






























Scheme 20. 1,5-Syn aldol induction of methylketones 44 50. 
 
which afforded methylketone 57 after few steps (Scheme 22). The 
coupling between the boron enolate of methylketone 57 with the 
aldehyde provided aldol adduct 58 with excellent levels of selectiv-
ity in favor of the 1,5-anti isomer with Felkin addition. 
2.2.3. Total Synthesis of ( )-Ericanone 
( )-Ericanone was isolated from Erica cinerea in 2011 [50]. Dias et 
al., reported in 2013 the first stereoselective total synthesis of ( )-
ericanone employing the 1,5-anti aldol reaction to install a C7 
stereocenter (Scheme 23) [51]. This approach also established the 
absolute configuration of the natural product. 
3. MUKAIYAMA ALDOL REACTIONS 
The Mukaiyama aldol reaction involves the Lewis acid-
mediated addition of enolsilanes to aldehydes [52]. The reactions 
occur via an “open” transition state without coordination of the 
aldehyde to the enolate. The stable and isolable silyl enol ether is a 
weak nucleophile. The Lewis acid in the reaction strongly interacts 
with carbonyl compounds, generating an active electrophilic spe-
cies that can easily react, even with weaker carbon nucleophiles. 
TiCl4 was the first Lewis-acid employed by Mukaiyama, but other 
Lewis acids (e.g., SnCl4, BF3.OEt2, MgBr2.OEt2, Sn(OTf)2, 
Me2AlCl, and LiClO4) have also been widely used. 
3.1. Total Synthesis of ( )-Goniotrionin 
( )-Goniotrionin, a polyketide belonging Annonaceous aceto-
genin, was isolated in 1998 by McLaughlin et al. from Gonio-
thalamus giganteus [53] and exhibited a high cytotoxicity against 
the A-549, MCF-7, A-498, and PACA-2 cancer cell lines. It was 
105 times more potent than adriamycin against the breast cancer 
cell line MCF-7. In 2012, Dias and Ferreira completed a stereose-
lective total synthesis of ( )-goniotrionin (Scheme 24) [54]. The 
late-stage 1,2-syn Mukaiyama aldol reaction under chelation control 
using MgBr2.Et2O as the Lewis acid produced the C14 stereocenter 
through the reaction between enolsilane 59 and aldehyde 60 and 
gave aldol adduct 61, with 59% yield and excellent diastereoselec-
tivity. The Cram-chelate transition state TS19 explains the di-
astereoselectivity of the reaction. 
3.2. Total Synthesis of (±)-Invictolide 
A stereoselective synthesis of (±)-invictolide, a component of 
the queen recognition pheromone in Solenopsis invicta, was dis-
closed by Pilli and Murta. Employing a TiCl4-mediated addition of 
silyl ketene thioacetal 62 to (±)-3-(benzyloxy)-2-methylpropion-
aldehyde 63, the authors observed the exclusive formation of 
thioester 64 in 65% yield, which produced (±)-invictolide after 
several more steps (Scheme 25) [55]. 
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MeOH (60%, 2 steps)
2) HF:py, MeCN (quantitative)
 
Scheme 23. Total synthesis of ( )-ericanone. 















































































Scheme 25. Total synthesis of (±)-invictolide. 
 
3.3. Total Synthesis of Cryptomoscatones D1 and D2 
The synthesis of cryptomoscatones D1 and D2 were disclosed 
by Pilli et al., in 2014. They used a Mukaiyama aldol reaction be-
tween aldehyde 65 and enolsilane 66 to yield 67 with low diastereo-
selectivity and inserted the C8 stereocenter in the natural products 
(Scheme 26) [56]. 
4. ORGANOCATALYTIC ALDOL REACTIONS 
The use of catalytic methods to perform direct aldol reactions is 
one of the most attractive ways to control chemo-, regio-, diastereo- 
and enantioselectivity. This goal can be accomplished using small 
organic molecules of low-molecular weight, also known as organo-
catalysts [57], which are readily available and afford mild and sim-
ple reaction conditions. Asymmetric organocatalysts stand out for 
their variety of activation modes, classified by the ligand character 
of the substrate-catalyst interaction. An organocatalyst can act 
through both covalent and non-covalent interactions and/or display 
a dual acid/base character (“bifunctional catalysts”). 
4.1. Total Synthesis of (R)-Convolutamydine A 
Convolutamydines A–E are alkaloids that were isolated in 1995 
from Amathia convoluta [58]. Convolutamydines A exhibited cyto-
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toxicity against L1210 murine leukemia and RB human epidermoid 
carcinoma cells. In 2006, Garden, Tomasini et al. disclosed the total 
synthesis of (R)-convolutamydine A using an organocatalytic aldol 
reaction (Scheme 27) [59]. The dipeptide catalyzed the addition of 
acetone to 4,6-dibromoisatin 68, producing the quaternary C3 
stereocenter in (R)-Convolutamydine A through TS20. 
CONCLUSION 
Due to excellent predictability and selectivity levels, research 
has been devoted to the applications of auxiliary-driven stereoselec-
tive aldol reactions in the synthesis of bioactive compounds in re-
cent years in Brazil. Despite the ease with which chiral auxiliaries 
are introduced and removed, their use adds at least two steps to the 
synthetic strategy. In times where synthetic efficiency becomes 
increasingly important, we should expect that research groups give 
preference to stereoselective metal- and organocatalysed aldol reac-
tions. Nonetheless, catalyst mediated aldol reactions are strongly 
substrate-dependent, thus research will focus on the development 
and application of new catalysts in the coming years. 
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